![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Asthma |
|
Free Subscription
4 Allergy |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Asthma is free of charge.
Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex,
Weight, and Oral Steroid Treatment Than Disease Severity.
Allergy. 2026 Apr 3. doi: 10.1111/all.70318.
PubMed
Abstract available
Omalizumab Dose-Related Efficacy in a Cohort of Children With Severe Food
Allergy: OSAFA Observational Study.
Allergy. 2026 Jan 19. doi: 10.1111/all.70228.
PubMed
Abstract available
Protective Role for Itaconate During Inhaled Allergen Challenge.
Allergy. 2025 Oct 24. doi: 10.1111/all.70107.
PubMed
Abstract available
The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic
Inflammation.
Allergy. 2026;81:1173-1192.
PubMed
Abstract available
Corrigendum to 'Skin as the target for allergy prevention and treatment' [Annals
of Allergy, Asthma & Immunology, Volume 133, Issue 2 (2024) 133-143].
Ann Allergy Asthma Immunol. 2026 Mar 28:S1081-1206(26)00116.
PubMed
Suggested novel risk factors for Swimming-Induced Pulmonary Edema - asthma and
limited open water swimming experience.
Chest. 2026 Mar 26:S0012-3692(26)00409-5. doi: 10.1016/j.chest.2026.
PubMed
Abstract available
Pulmonary Dynamics of the Bronchodilator Response in Volume-Responsive Asthma and
COPD.
Chest. 2026 Mar 26:S0012-3692(26)00418-6. doi: 10.1016/j.chest.2026.
PubMed
Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in
Patients With Severe Asthma.
Clin Exp Allergy. 2026 Mar 27. doi: 10.1111/cea.70294.
PubMed
Current and Emerging Biologic Therapies for Severe Asthma.
Drugs. 2026 Mar 28. doi: 10.1007/s40265-026-02310.
PubMed
Abstract available
Mepolizumab for the treatment of refractory chronic cough in patients with
eosinophilic airways disease (MUCOSA): a randomised, double-blind,
parallel-group, placebo-controlled trial.
Eur Respir J. 2026;67:2501573.
PubMed
Abstract available
Comparative Study on Two Epidemic Thunderstorm-Asthma Events: A Retrospective
Analysis of Cases in Yulin in 2022 and 2025.
Int Arch Allergy Immunol. 2026 Apr 2:1-20. doi: 10.1159/000551697.
PubMed
Abstract available
Paternal snus use in puberty and increased risk for asthma and allergies in
offspring: a RHINE/RHINESSA two-generation study.
Int J Epidemiol. 2026;55:dyag035.
PubMed
Abstract available
Deep learning and statistical methods identify novel asthma risk variants in
Europeans.
J Allergy Clin Immunol. 2026 Apr 1:S0091-6749(26)00221.
PubMed
Abstract available
Nurse-Led Family Interactive Intervention in Children with Bronchial Asthma: A
Randomized Controlled Trial.
J Asthma. 2026 Apr 2:1-12. doi: 10.1080/02770903.2026.2654592.
PubMed
Abstract available
The asthma-anxiety connection: friends or foes?
J Asthma. 2026 Apr 2:1-7. doi: 10.1080/02770903.2026.2654583.
PubMed
Abstract available
FDA Approves New Generic Inhaler for Asthma Treatment.
JAMA. 2026 Mar 27. doi: 10.1001/jama.2026.1024.
PubMed
Single Maintenance and Reliever Therapy for the Pediatric Patients With Asthma.
Pediatr Rev. 2026;47:234-236.
PubMed
Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that
concurrently reverse disease signatures across multiple immune cell-types.
PLoS Comput Biol. 2026;22:e1014081.
PubMed
Abstract available
The transition from winter to spring has an impact on the airway metabolome
profile of asthmatic horses.
PLoS One. 2026;21:e0346250.
PubMed
Abstract available
Deciphering the synergistic mechanism of a novel flavonoid-antioxidant
combination for asthma by combining systems pharmacology and experimental
validation.
PLoS One. 2026;21:e0346165.
PubMed
Abstract available
Factors associated with wheezing in Indigenous children and adolescents: A
systematic review of the global literature.
PLoS One. 2026;21:e0345711.
PubMed
Abstract available
Development and short-term effectiveness of a theory-informed, nurse-led
structured rehabilitation consultation in primary care asthma management.
Respir Med. 2026;256:108797.
PubMed
Abstract available
B cell activating factor (BAFF) levels are associated with failed remission after
12 months of treatment with benralizumab and mepolizumab in severe asthma.
Respir Res. 2026 Apr 2. doi: 10.1186/s12931-026-03500.
PubMed
A 3-year prospective study to assess clinical characteristics and risk factors
for exacerbations in patients with asthma-COPD overlap based on the GINA
guideline compared with patients with asthma and COPD.
Respir Res. 2026 Mar 29. doi: 10.1186/s12931-026-03643.
PubMed
Biologic Therapy Timing and Severe Asthma Progression: Insights from the Italian
Registry on Severe Asthma.
Respiration. 2026 Mar 30:1-12. doi: 10.1159/000551651.
PubMed
Abstract available
Thank you for your interest in scientific medicine.